$CHTH
CNL Healthcare Properties, Inc.

2016 Q1 Form 10-Q Financial Statement

#000156459016019102 Filed on May 11, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $92.96M $65.03M
YoY Change 42.94% 95.44%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.230M $898.0K
YoY Change 36.97% 351.26%
Operating Profit -$991.0K -$7.909M
YoY Change -87.47% 7.24%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$13.33M -$10.03M
YoY Change 32.87% 93.74%
Pretax Income -$14.32M -$17.94M
YoY Change -20.18% 42.92%
Income Tax $120.0K $64.00K
% Of Pretax Income
Net Earnings -$14.44M -$18.00M
YoY Change -19.77% 43.74%
Net Earnings / Revenue -15.54% -27.68%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 174.4M 133.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $116.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.808B $2.078B
YoY Change 35.13% 73.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $1.586B $1.075B
YoY Change 47.57% 55.83%
SHAREHOLDERS EQUITY
Retained Earnings -$165.6M -$101.1M
YoY Change 63.8% 134.53%
Common Stock $1.535B $1.349M
YoY Change 113666.12% 99.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.220B $1.003B
YoY Change
Total Liabilities & Shareholders Equity $2.808B $2.078B
YoY Change 35.13% 73.01%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$14.44M -$18.00M
YoY Change -19.77% 43.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $76.06M
YoY Change -59.29%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $7.729M $5.600M
YoY Change 38.02% 100.14%
Common Stock Issuance & Retirement, Net $2.739M -$179.9M
YoY Change -101.52% 107.47%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures $76.06M
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9766000
CY2016Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3976000
CY2015Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1803000
CY2016Q1 us-gaap Liabilities
Liabilities
1585930000
CY2015Q4 us-gaap Liabilities
Liabilities
1572067000
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
551000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10287000
CY2016Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
130997000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17678000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
1220442000
CY2016Q1 us-gaap Minority Interest
MinorityInterest
1462000
CY2016Q1 chp Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
1222446000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2808376000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 chp Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000
CY2015Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000
CY2015Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0
CY2016Q1 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0
CY2015Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
175824000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174430000
CY2016Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
30576000
CY2015Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
21640000
CY2015Q1 us-gaap Health Care Organization Resident Service Revenue
HealthCareOrganizationResidentServiceRevenue
40032000
CY2016Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
5040000
CY2015Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
3361000
CY2016Q1 us-gaap Revenues
Revenues
92960000
CY2015Q1 us-gaap Revenues
Revenues
65033000
CY2016Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
46036000
CY2015Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
32312000
CY2016Q1 us-gaap Other Liabilities
OtherLiabilities
47934000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
1751000
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1532954000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165588000
CY2015Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2330000
CY2015Q1 us-gaap Asset Management Costs
AssetManagementCosts
4210000
CY2015Q1 us-gaap Owned Property Management Costs
OwnedPropertyManagementCosts
3254000
CY2015Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
4661000
CY2016Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-785000
CY2015Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-863000
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
93951000
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
72942000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-991000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7909000
CY2016Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
28000
CY2015Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
60000
CY2016Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
13238000
CY2016Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-120000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13330000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14321000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
120000
CY2016Q1 us-gaap Profit Loss
ProfitLoss
-14441000
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-18005000
CY2016Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000
CY2015Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-14442000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-18000000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
174681000
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
131880000
CY2015Q1 chp Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
-5268000
CY2015Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-74000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32565000
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23293000
CY2015Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
9866000
CY2015Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-226000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10032000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17941000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64000
CY2015Q4 us-gaap Assets
Assets
2831169000
CY2015Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
831825000
CY2015Q4 us-gaap Line Of Credit
LineOfCredit
656284000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
11317000
CY2016Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-19463000
CY2016Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
7729000
CY2015Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
5600000
CY2016Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
542000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
1744000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1528781000
CY2015Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
112543000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9747000
CY2016Q1 us-gaap Line Of Credit
LineOfCredit
626528000
CY2015Q4 us-gaap Other Liabilities
OtherLiabilities
41938000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
1257089000
CY2015Q4 us-gaap Minority Interest
MinorityInterest
1462000
CY2015Q4 chp Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
1259102000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2831169000
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q1 chp Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Assets
Assets
2808376000
CY2016Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
862483000
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151146000
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176924000
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
175253000
CY2016Q1 us-gaap Health Care Organization Resident Service Revenue
HealthCareOrganizationResidentServiceRevenue
57344000
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1472000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3337000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2019000
CY2016Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
105000
CY2016Q1 us-gaap Asset Management Costs
AssetManagementCosts
6653000
CY2016Q1 us-gaap Owned Property Management Costs
OwnedPropertyManagementCosts
4470000
CY2016Q1 chp Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
-7948000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22373000
CY2016Q1 chp Other Comprehensive Income Loss Reclassification Of Cash Flow Hedges Due To Ineffectiveness Net Of Tax
OtherComprehensiveIncomeLossReclassificationOfCashFlowHedgesDueToIneffectivenessNetOfTax
-18000
CY2016Q1 chp Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
-1000
CY2015Q1 chp Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
-6000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7931000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5200000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-22373000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-23200000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23200000
CY2016Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10725000
CY2016Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
2695000
CY2016Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10000
CY2016Q1 chp Adjustments To Additional Paid In Capital Distribution To Holder Of Promoted Interest
AdjustmentsToAdditionalPaidInCapitalDistributionToHolderOfPromotedInterest
3850000
CY2016Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18454000
CY2014Q4 chp Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
872160000
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188386000
CY2015Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1942000
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
18558000
CY2015Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13248000
CY2015Q1 chp Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
1003593000
CY2016Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1058
CY2015Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1058
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
16008000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76060000
CY2016Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
17526000
CY2015Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
17567000
CY2015Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1785000
CY2016Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-520000
CY2015Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-2974000
CY2016Q1 us-gaap Payments For Leasing Costs
PaymentsForLeasingCosts
985000
CY2015Q1 us-gaap Payments For Leasing Costs
PaymentsForLeasingCosts
418000
CY2015Q1 us-gaap Payments For Deposits On Real Estate Acquisitions
PaymentsForDepositsOnRealEstateAcquisitions
750000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-93606000
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
180738000
CY2016Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
32000
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
19388000
CY2016Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
10000
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2739000
CY2015Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
872000
CY2016Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15113000
CY2016Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
45000000
CY2015Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
31403000
CY2016Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
35285000
CY2015Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
18187000
CY2016Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
4738000
CY2015Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
33936000
CY2016Q1 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
50000
CY2016Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
587000
CY2016Q1 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
845000
CY2015Q1 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
427000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-11332000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
107299000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14787000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25010000
CY2016Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2304994000
CY2016Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
62620000
CY2016Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
136730000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91355000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116365000
CY2016Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
12647000
CY2015Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
9181000
CY2016Q1 chp Redemptions Payable
RedemptionsPayable
2695000
CY2015Q1 chp Redemptions Payable
RedemptionsPayable
1942000
CY2016Q1 chp Payment Of Distribution To Holder Of Promoted Interest
PaymentOfDistributionToHolderOfPromotedInterest
3850000
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates<font style="font-style:normal;"> &#8212;</font><font style="font-weight:normal;font-style:normal;"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the allocation of purchase price, the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted stock shares issued to the Advisor or Property Manager.&nbsp;&nbsp;Accordingly, actual results could differ from those estimates.</font></p></div>
CY2016Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-06-08
CY2015Q4 chp Sale Of Additional Shares Of Common Stock
SaleOfAdditionalSharesOfCommonStock
20000000
CY2016Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
231449000
CY2015Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
229046000
CY2015Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2297336000
CY2015Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
60601000
CY2015Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
116807000
CY2016Q1 chp Real Estate Development Expense
RealEstateDevelopmentExpense
71064000
CY2016Q1 chp Estimated Remaining Development Costs
EstimatedRemainingDevelopmentCosts
127953000
CY2016Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
88141000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
74895000
CY2016Q1 chp Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
3008000
CY2015Q4 chp Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
2581000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13200000
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10200000
CY2016Q1 chp Amortization Of Intangible Liabilities
AmortizationOfIntangibleLiabilities
400000
CY2015Q1 chp Amortization Of Intangible Liabilities
AmortizationOfIntangibleLiabilities
400000
CY2016Q1 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
79400000
CY2016Q1 us-gaap Variable Interest Entity Qualitative Or Quantitative Information
VariableInterestEntityQualitativeOrQuantitativeInformation
As of March 31, 2016, the Company has 12 subsidiaries which are VIEs due to the following factors and circumstances:  Three of these subsidiaries are single property entities, designed to own and lease their respective properties to multiple tenants, which are subject to either a ground lease or an air rights lease that include buy-out and put options held by either the tenant or landlord under the applicable lease. These buy-out and put options have the potential to cap either the Company’s expected returns or its obligation to absorb the losses of the properties.  Six of these subsidiaries are entities with real estate under development or completed developments in which there is insufficient equity at risk due to the development nature of each entity.  Two of these subsidiaries are joint ventures with real estate under development in which there is insufficient equity at risk due to the development nature of each joint venture.  One of these subsidiaries is a joint venture in which the Company’s co-venture partner has an equity interest that consists of non-substantive protective voting rights, but not any participating or kick-out rights.
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6481000
CY2016Q1 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
79000
CY2016Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
CY2016Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6560000
CY2016Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
871202000
CY2015Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
840656000
CY2016Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
182000
CY2015Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
221000
CY2016Q1 chp Loan Costs Net
LoanCostsNet
8537000
CY2015Q4 chp Loan Costs Net
LoanCostsNet
8610000
CY2016Q1 us-gaap Long Term Debt
LongTermDebt
1489011000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
1488109000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
1040000
CY2016Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
40000
CY2015Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
100000
CY2016Q1 chp Operating Expenses Reimbursement Percentage Of Average Investment In Assets
OperatingExpensesReimbursementPercentageOfAverageInvestmentInAssets
0.02
CY2016Q1 chp Operating Expenses Reimbursement Percentage Of Net Income
OperatingExpensesReimbursementPercentageOfNetIncome
0.25
CY2015Q1 chp Selling Commissions
SellingCommissions
4022000
CY2015Q1 chp Marketing Support Fees
MarketingSupportFees
5387000
CY2015Q1 chp Fees And Commission Expenses
FeesAndCommissionExpenses
9409000
CY2015Q1 chp Offering Costs
OfferingCosts
882000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
1230000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
898000
CY2016Q1 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
1260000
CY2015Q1 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
1884000
CY2015Q1 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
1416000
CY2016Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
9657000
CY2015Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
9166000
CY2015Q4 chp Offering Costs Due
OfferingCostsDue
32000
CY2016Q1 chp Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
1106000
CY2015Q4 chp Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
935000
CY2016Q1 chp Related Party Transaction Acquisition Fees Payable
RelatedPartyTransactionAcquisitionFeesPayable
20000
CY2015Q4 chp Related Party Transaction Acquisition Fees Payable
RelatedPartyTransactionAcquisitionFeesPayable
12000
CY2016Q1 chp Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
1126000
CY2015Q4 chp Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
979000
CY2015Q4 chp Due To Related Party Investment Services Fees
DueToRelatedPartyInvestmentServicesFees
182000
CY2016Q1 chp Property Management Fees Due To Related Party
PropertyManagementFeesDueToRelatedParty
819000
CY2015Q4 chp Property Management Fees Due To Related Party
PropertyManagementFeesDueToRelatedParty
418000
CY2016Q1 chp Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
2031000
CY2015Q4 chp Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
224000
CY2016Q1 chp Capitalized Amount Of Construction Management Fees
CapitalizedAmountOfConstructionManagementFees
200000
CY2015Q1 chp Capitalized Amount Of Construction Management Fees
CapitalizedAmountOfConstructionManagementFees
300000
CY2016Q1 chp Capitalized Amount Of Asset Management Fees
CapitalizedAmountOfAssetManagementFees
200000
CY2015Q1 chp Capitalized Amount Of Asset Management Fees
CapitalizedAmountOfAssetManagementFees
100000
us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
0.0025
CY2016Q1 us-gaap Dividends Common Stock
DividendsCommonStock
7700000
CY2015Q1 us-gaap Dividends Common Stock
DividendsCommonStock
5600000
CY2016Q1 us-gaap Operating Support From Adviser Amount
OperatingSupportFromAdviserAmount
400000
CY2015Q1 us-gaap Operating Support From Adviser Amount
OperatingSupportFromAdviserAmount
500000
CY2016Q1 chp Common Stock Offering Price
CommonStockOfferingPrice
10.58
CY2016Q1 chp Common Stock Offering Price
CommonStockOfferingPrice
9.75
CY2016Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.0353
CY2016Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.0353
us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
0
CY2016Q1 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
0
CY2015Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9.75
CY2016Q1 chp Average Redemption Common Stock Price Per Share
AverageRedemptionCommonStockPricePerShare
9.73
CY2015Q1 chp Average Redemption Common Stock Price Per Share
AverageRedemptionCommonStockPricePerShare
9.51
CY2016Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-7931000
CY2015Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-5200000
CY2016Q1 chp Number Of Promoted Interest Agreements With Third Party Developers
NumberOfPromotedInterestAgreementsWithThirdPartyDevelopers
10

Files In Submission

Name View Source Status
0001564590-16-019102-index-headers.html Edgar Link pending
0001564590-16-019102-index.html Edgar Link pending
0001564590-16-019102.txt Edgar Link pending
0001564590-16-019102-xbrl.zip Edgar Link pending
chp-10q_20160331.htm Edgar Link pending
chp-20160331.xml Edgar Link completed
chp-20160331.xsd Edgar Link pending
chp-20160331_cal.xml Edgar Link unprocessable
chp-20160331_def.xml Edgar Link unprocessable
chp-20160331_lab.xml Edgar Link unprocessable
chp-20160331_pre.xml Edgar Link unprocessable
chp-ex311_70.htm Edgar Link pending
chp-ex312_68.htm Edgar Link pending
chp-ex321_69.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gaekgnfcosfd000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending